APCB | CGCP | APCB / CGCP | |
Gain YTD | 4.056 | 4.520 | 90% |
Net Assets | 875M | 5.45B | 16% |
Total Expense Ratio | 0.37 | 0.34 | 109% |
Turnover | 125.20 | 83.00 | 151% |
Yield | 4.64 | 5.10 | 91% |
Fund Existence | 2 years | 3 years | - |
APCB | CGCP | |
---|---|---|
RSI ODDS (%) | 3 days ago26% | 3 days ago44% |
Stochastic ODDS (%) | 3 days ago48% | 3 days ago57% |
Momentum ODDS (%) | 3 days ago38% | 3 days ago53% |
MACD ODDS (%) | 3 days ago45% | 3 days ago58% |
TrendWeek ODDS (%) | 3 days ago42% | 3 days ago63% |
TrendMonth ODDS (%) | 3 days ago60% | 3 days ago62% |
Advances ODDS (%) | 27 days ago60% | 17 days ago57% |
Declines ODDS (%) | 3 days ago38% | 3 days ago54% |
BollingerBands ODDS (%) | 3 days ago50% | 3 days ago52% |
Aroon ODDS (%) | 3 days ago53% | 3 days ago70% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HBGHX | 13.67 | 0.21 | +1.56% |
Hartford Healthcare HLS IB | |||
BOPIX | 29.69 | 0.11 | +0.37% |
Sterling Capital Special Opps Inst | |||
PACLX | 37.25 | -0.01 | -0.03% |
T. Rowe Price Capital Appreciation Adv | |||
CSMMX | 24.37 | -0.04 | -0.16% |
Invesco Summit C | |||
SAMVX | 12.20 | -0.09 | -0.73% |
Virtus Ceredex Mid-Cap Value Equity A |
A.I.dvisor tells us that CGCP and NFE have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGCP and NFE's prices will move in lockstep.
Ticker / NAME | Correlation To CGCP | 1D Price Change % | ||
---|---|---|---|---|
CGCP | 100% | -0.18% | ||
NFE - CGCP | 4% Poorly correlated | -3.56% |